Anoro Ellipta inhalation powder recalled for failed release testing defect
GlaxoSmithKline is recalling 67,508 Anoro Ellipta inhalers nationwide because coarse particle mass failed release testing and was found out of specification. No illnesses have been reported.
- Product
- ANORO ELLIPTA — ANORO ELLIPTA (UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE)
- Category
- Drug
- Distribution
- Distributed nationwide